Morning Overview on MSN
A new blood test caught stage-one cancer with 81% accuracy before any scan could
Researchers working on blood-based cancer screening have reached a threshold that could change how early-stage tumors are ...
BOULDER, Colo.--(BUSINESS WIRE)--Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung disease, announced today the validation and launch of a new method of ...
AUSTIN, Texas and FRANKLIN LAKES, N.J., May 11, 2022 /PRNewswire/ -- Babson Diagnostics, a science-first, health care technology company, and BD (Becton, Dickinson and Company) (NYSE: BDX), a leading ...
Cancerguard detects multiple cancers early by identifying specific DNA and protein markers in a blood sample. The test is available for adults aged 50-84 without cancer in the past three years, but it ...
Unlike conventional screening methods that typically target a single cancer, Shield MCD is designed to detect signals ...
Capillary device supports in-office blood collection in diverse practice locations without the need for venipuncture BOULDER, Colo.--(BUSINESS WIRE)-- Biodesix, Inc. (Nasdaq: BDSX), a leading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results